Payment Terms Paypal, Cash in Advance (CID), Cheque, Telegraphic Transfer (T/T), Western Union, Others Telegraphic Transfer (T/T) People Also Viewed
For those primarily interested in weight management, its essential to look into other options
Targeted Stubborn Fat Reduction AOD-9604 appears to preferentially mobilize fat from areas rich in beta-3 adrenergic receptors, which includes abdominal and visceral fat
Compound Specifications Synthetic Pentadecapeptide Laboratory Research Use Only Product Details Sizes: 5mg, 10mg Compound: BPC-157 Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val CAS: 137525-51-0 Molecular Weight: 1419.53 Da Form: Lyophilized powder Documentation: Batch-specific analytical records where available Testing: View COA documentation Testing: View COA (Verified by Janoshik) BPC-157 documentation path This page is built as a documentation-first reference page for researchers comparing compound identity, vial size, analytical records, and literature context
The city of Newport Beach helped make it happen
This appetite-neutral characteristic distinguishes AOD-9604 from medications like GLP-1 agonists (Semaglutide, Tirzepatide) that work primarily through appetite suppression